Furthermore, evidence have been provided that CD44 exists in two different states, which differ in HA-binding affinity, i.e, active on human breast cancer cells, and inactive on normal cells, and it may shift from inactive to active conformation upon appropriate stimuli within the TME [78]. This evidence concerns the gene CD44 and breast carcinoma.